• Die Fortschritte der Forschung sind die einzige Hoffnung der Patienten auf wirksame Therapien!

  • Unterstützen Sie die Forschung an seltenen genetischen Muskelkrankheiten!

ENMC workshops


Next deadline for a workshop application: September 15

*****************************************************

ENMC Workshopsbericht

The position of the neuromuscular patient in Shared Decision Making. 19-20 January 2018

Auf deutsch verfügbar

Bone protective therapy in DMD. 1-3 June 2018

Auf englisch verfügbar

************************************************************

Molecular mechanisms of muscle wasting during aging and disease

Ascona, 23-28 September 2018

This meeting will focus on the molecular mechanisms involved in muscle wasting diseases including cachexia, sarcopenia and muscular dystrophies. Its focus on disease aspects in skeletal muscle, its interactive format and its small size makes this meeting unique.

Abstract submission deadline 17 June

*****************************************************************************3

Effect of hypnotic suggestion on knee extensor neuromuscular properties in resting and fatigued states.

Dittrich N, Agostino D, Antonini Philippe R, Guglielmo LGA, Place N.
PLoS One. 2018 Apr 23;13(4):e0195437.

26 April 2018

Repurposing the Selective Oestrogen Receptor Modulator Tamoxifen for the Treatment of Duchenne Muscular Dystrophy.

Gayi E, Neff LA, Ismail HM, Ruegg UT, Scapozza L, Dorchies OM.
Chimia (Aarau). 2018 Apr 25;72(4):238-240.

25 April 2018

Relation of nNOS isoforms to mitochondrial density and PGC-1alpha expression in striated muscles of mice.

Baum O, Aaldijk D, Engeli AL, Spree M, Summermatter S, Handschin C, Zakrzewicz A.
Nitric Oxide. 2018 Apr 17;77:35-43.

17 April 2018

The role of mitochondria in stem cell fate and aging.

Zhang H, Menzies KJ, Auwerx J.
Development. 2018 Apr 13;145(8).

13 April 2018